
Hypertension Drug Market Share, Size, Trends, Industry Analysis Report, By Distribution Channel (Retail Pharmacies, E-Commerce Pharmacies, Hospital Pharmacies); By Condition (Primary, Secondary); By Type; By Medication Type; By Region; Segment Forecast, 2
Description
Hypertension Drug Market Share, Size, Trends, Industry Analysis Report, By Distribution Channel (Retail Pharmacies, E-Commerce Pharmacies, Hospital Pharmacies); By Condition (Primary, Secondary); By Type; By Medication Type; By Region; Segment Forecast, 2024 - 2032
The global hypertension drug market size is expected to reach USD 36.06 billion by 2032, according to a new study by Polaris Market Research. The report “Hypertension Drug Market Share, Size, Trends, Industry Analysis Report, By Distribution Channel (Retail Pharmacies, E-Commerce Pharmacies, Hospital Pharmacies); By Condition (Primary, Secondary); By Type; By Medication Type; By Region; Segment Forecast, 2022 - 2030” gives a detailed insight into current market dynamics and provides analysis on future market growth.
High growth in hypertension drugs is mainly due to an increase in hypertension patients, an increase in tobacco consumption, and government initiatives. A constant workload and unhealthy eating habits are the leading causes of hypertension. These factors have contributed to the rise in cases of hypertension.
Globally, the number of hypertension cases has increased significantly. In addition, there is a critical need to raise awareness about the complications associated with hypertension. The significant driver of the global market’s growth.
The global market for hypertension medications is expanding due to the epidemic rise in the prevalence of hypertension. Studies have revealed that hypertension has developed into a condition that, if untreated in the beginning stages, can progress and become a fatal condition that may affect the patient’s heart. In an effort to increase public awareness, the effects of hypertension are being made more widely known. In the recent past, the world has become more digital, which has resulted in a situation where lifestyles are becoming more sedentary.
Hypertension Drug Market Report Highlights
- Angiotensin II Receptor Blockers segment is anticipated to grow at a significant rate over the forecast period owing to the rising high blood pressure, heart failure, and chronic kidney disease.
- Primary hypertension accounted for a major revenue share. It’s linked to genetics, lack of exercise, a deficient diet, an excessive amount of salt and obesity. It is by far the most common form of primary hypertension
- North America is expected to grow at a significant CAGR over the projected period on account of the increasing consumer awareness regarding the adverse of high blood pressure, obesity etc. which cause several diseases such as cancer and other cardiovascular disorders
- The global market is highly competitive due to the existence of large market players with a global presence, including Takeda Pharmaceutical Co., Pfizer, Inc., Astra Zeneca Plc, Dr. Reddy's Laboratories, Novartis, Abbott, Sanofi, and Bayer AG
Polaris Market Research has segmented the hypertension drug market report based on type, condition, medication, distribution channel and region:
Hypertension Drug, Type Outlook (Revenue - USD Billion, 2018 - 2030)
- Diuretics
- Alpha-Blockers
- Calcium Channel Blockers
- Beta blockers
- Angiotensin-Converting Enzyme (ACE)
- Inhibitors
- Renin Inhibitors
- Angiotensin II Receptor Blockers (ARBs)
- Vasodilators
- Others
Hypertension Drug, Condition Outlook (Revenue - USD Billion, 2018 - 2030)
- Primary
- Secondary
Hypertension Drug, Medication Outlook (Revenue - USD Billion, 2018 - 2030)
- Combination Therapy
- Monotherapy
- Fixed Dose Combinations Pharmacies
Hypertension Drug, Distribution Channel Outlook (Revenue - USD Billion, 2018 - 2030)
- Retail Pharmacies
- E-Commerce Pharmacies
- Hospital Pharmacies
Hypertension Drugs, Regional Outlook (Revenue - USD Billion, 2018 - 2030)
- North America
U.S
Canada
- Europe
Germany
UK
France
Italy
Spain
Russia
Netherlands
- Asia Pacific
China
India
Japan
South Korea
Indonesia
Malaysia
- Latin America
Argentina
Brazil
Mexico
- Middle East & Africa
UAE
Saudi Arabia
Israel
South Africa
Table of Contents
118 Pages
- 1. Introduction
- 1. Report Description
- 1. Objectives of the Study
- 2. Market Scope
- 3. Assumptions
- 2. Stakeholders
- 2. Executive Summary
- 1. Market Highlights
- 3. Research Methodology
- 1. Overview
- 1. Data Mining
- 2. Data Sources
- 1. Primary Sources
- 2. Secondary Sources
- 4. Global Hypertension Drug Market Insights
- 1. Hypertension Drug – Industry Snapshot
- 2. Hypertension Drug Market Dynamics
- 1. Drivers and Opportunities
- 1. High growth potential in developing economies
- 2. Surge in healthcare expenditure worldwide
- 2. Restraints and Challenges
- 1. Rising healthcare costs
- 3. Porter’s Five Forces Analysis
- 1. Bargaining Power of Suppliers (Moderate)
- 2. Threats of New Entrants: (Low)
- 3. Bargaining Power of Buyers (Moderate)
- 4. Threat of Substitute (Moderate)
- 5. Rivalry among existing firms (High)
- 4. PESTLE Analysis
- 5. Hypertension Drug Industry Trends
- 6. Value Chain Analysis
- 7. COVID-19 Impact Analysis
- 5. Global Hypertension Drug Market, by Condition
- 1. Key Findings
- 2. Introduction
- 1. Global Hypertension Drug Market, by Condition, 2018 - 2030 (USD Billion)
- 3. Primary
- 1. Global Hypertension Drug Market, by Primary, by Region, 2018 - 2030 (USD Billion)
- 4. Secondary
- 1. Global Hypertension Drug Market, by Secondary, by Region, 2018 - 2030 (USD Billion)
- 6. Global Hypertension Drug Market, by Distribution Channel
- 1. Key Findings
- 2. Introduction
- 1. Global Hypertension Drug Market, by Distribution Channel, 2018 - 2030 (USD Billion)
- 3. Retail Pharmacies
- 1. Global Hypertension Drug Market, by Retail Pharmacies, by Region, 2018 - 2030 (USD Billion)
- 4. E-Commerce Pharmacies
- 1. Global Hypertension Drug Market, by E-Commerce Pharmacies, by Region, 2018 - 2030 (USD Billion)
- 5. Hospital Pharmacies
- 1. Global Hypertension Drug Market, by Hospital Pharmacies, by Region, 2018 - 2030 (USD Billion)
- 7. Global Hypertension Drug Market, by Type
- 1. Key Findings
- 2. Introduction
- 1. Global Hypertension Drug Market, by Type, 2018 - 2030 (USD Billion)
- 3. Diuretics, Alpha-Blockers
- 1. Global Hypertension Drug Market, by Diuretics, Alpha-Blockers, by Region, 2018 - 2030 (USD Billion)
- 4. Calcium Channel Blockers
- 1. Global Hypertension Drug Market, by Calcium Channel Blockers, by Region, 2018 - 2030 (USD Billion)
- 5. Beta blockers
- 1. Global Hypertension Drug Market, by Beta blockers, by Region, 2018 - 2030 (USD Billion)
- 6. Angiotensin-Converting Enzyme (A.C.E.)
- 1. Global Hypertension Drug Market, by Angiotensin-Converting Enzyme (A.C.E.), by Region, 2018 - 2030 (USD Billion)
- 7. Inhibitors
- 1. Global Hypertension Drug Market, by Inhibitors, by Region, 2018 - 2030 (USD Billion)
- 8. Renin Inhibitors
- 1. Global Hypertension Drug Market, by Renin Inhibitors, by Region, 2018 - 2030 (USD Billion)
- 9. Angiotensin II Receptor Blockers (A.R.B.s)
- 1. Global Hypertension Drug Market, by Angiotensin II Receptor Blockers (A.R.B.s), by Region, 2018 - 2030 (USD Billion)
- 10. Vasodilators
- 1. Global Hypertension Drug Market, by Vasodilators, by Region, 2018 - 2030 (USD Billion)
- 11. Others
- 1. Global Other Hypertension Drug Market, by Region, 2018 - 2030 (USD Billion)
- 8. Global Hypertension Drug Market, by Medication Type
- 1. Key Findings
- 2. Introduction
- 1. Global Hypertension Drug Market, by Medication Type, 2018 - 2030 (USD Billion)
- 3. Combination Therapy
- 1. Global Hypertension Drug Market, by Combination Therapy, by Region, 2018 - 2030 (USD Billion)
- 4. Monotherapy
- 1. Global Hypertension Drug Market, by Monotherapy, by Region, 2018 - 2030 (USD Billion)
- 5. Fixed Dose Combinations
- 1. Global Hypertension Drug Market, by Fixed Dose Combinations, by Region, 2018 - 2030 (USD Billion)
- 9. Global Hypertension Drug Market, by Geography
- 1. Key findings
- 2. Introduction
- 1. Hypertension Drug Market Assessment, By Geography, 2018 - 2030 (USD Billion)
- 3. Hypertension Drug Market – North America
- 1. North America: Hypertension Drug Market, by Condition, 2018 - 2030 (USD Billion)
- 2. North America: Hypertension Drug Market, by Medication Type, 2018 - 2030 (USD Billion)
- 3. North America: Hypertension Drug Market, by Distribution Channel, 2018 - 2030 (USD Billion)
- 4. North America: Hypertension Drug Market, by Type, 2018 - 2030 (USD Billion)
- 5. Hypertension Drug Market – U.S.
- 1. U.S.: Hypertension Drug Market, by Condition, 2018 - 2030 (USD Billion)
- 2. U.S.: Hypertension Drug Market, by Medication Type, 2018 - 2030 (USD Billion)
- 3. U.S.: Hypertension Drug Market, by Distribution Channel, 2018 - 2030 (USD Billion)
- 4. U.S.: Hypertension Drug Market, by Type, 2018 - 2030 (USD Billion)
- 6. Hypertension Drug Market – Canada
- 1. Canada: Hypertension Drug Market, by Condition, 2018 - 2030 (USD Billion)
- 2. Canada: Hypertension Drug Market, by Medication Type, 2018 - 2030 (USD Billion)
- 3. Canada: Hypertension Drug Market, by Distribution Channel, 2018 - 2030 (USD Billion)
- 4. Canada: Hypertension Drug Market, by Type, 2018 - 2030 (USD Billion)
- 4. Hypertension Drug Market – Europe
- 1. Europe: Hypertension Drug Market, by Condition, 2018 - 2030 (USD Billion)
- 2. Europe: Hypertension Drug Market, by Medication Type, 2018 - 2030 (USD Billion)
- 3. Europe: Hypertension Drug Market, by Distribution Channel, 2018 - 2030 (USD Billion)
- 4. Europe: Hypertension Drug Market, by Type, 2018 - 2030 (USD Billion)
- 5. Hypertension Drug Market – UK
- 1. UK: Hypertension Drug Market, by Condition, 2018 - 2030 (USD Billion)
- 2. UK: Hypertension Drug Market, by Medication Type, 2018 - 2030 (USD Billion)
- 3. UK: Hypertension Drug Market, by Distribution Channel, 2018 - 2030 (USD Billion)
- 4. UK: Hypertension Drug Market, by Type, 2018 - 2030 (USD Billion)
- 6. Hypertension Drug Market – France
- 1. France: Hypertension Drug Market, by Condition, 2018 - 2030 (USD Billion)
- 2. France: Hypertension Drug Market, by Medication Type, 2018 - 2030 (USD Billion)
- 3. France: Hypertension Drug Market, by Distribution Channel, 2018 - 2030 (USD Billion)
- 4. France: Hypertension Drug Market, by Type, 2018 - 2030 (USD Billion)
- 7. Hypertension Drug Market – Germany
- 1. Germany: Hypertension Drug Market, by Condition, 2018 - 2030 (USD Billion)
- 2. Germany: Hypertension Drug Market, by Medication Type, 2018 - 2030 (USD Billion)
- 3. Germany: Hypertension Drug Market, by Distribution Channel, 2018 - 2030 (USD Billion)
- 4. Germany: Hypertension Drug Market, by Type, 2018 - 2030 (USD Billion)
- 8. Hypertension Drug Market – Italy
- 1. Italy: Hypertension Drug Market, by Condition, 2018 - 2030 (USD Billion)
- 2. Italy: Hypertension Drug Market, by Medication Type, 2018 - 2030 (USD Billion)
- 3. Italy: Hypertension Drug Market, by Distribution Channel, 2018 - 2030 (USD Billion)
- 4. Italy: Hypertension Drug Market, by Type, 2018 - 2030 (USD Billion)
- 9. Hypertension Drug Market – Spain
- 1. Spain: Hypertension Drug Market, by Condition, 2018 - 2030 (USD Billion)
- 2. Spain: Hypertension Drug Market, by Medication Type, 2018 - 2030 (USD Billion)
- 3. Spain: Hypertension Drug Market, by Distribution Channel, 2018 - 2030 (USD Billion)
- 4. Spain: Hypertension Drug Market, by Type, 2018 - 2030 (USD Billion)
- 10. Hypertension Drug Market – Netherlands
- 1. Netherlands: Hypertension Drug Market, by Condition, 2018 - 2030 (USD Billion)
- 2. Netherlands: Hypertension Drug Market, by Medication Type, 2018 - 2030 (USD Billion)
- 3. Netherlands: Hypertension Drug Market, by Distribution Channel, 2018 - 2030 (USD Billion)
- 4. Netherlands: Hypertension Drug Market, by Type, 2018 - 2030 (USD Billion)
- 11. Hypertension Drug Market – Russia
- 1. Russia: Hypertension Drug Market, by Condition, 2018 - 2030 (USD Billion)
- 2. Russia.: Hypertension Drug Market, by Medication Type, 2018 - 2030 (USD Billion)
- 3. Russia: Hypertension Drug Market, by Distribution Channel, 2018 - 2030 (USD Billion)
- 4. Russia: Hypertension Drug Market, by Type, 2018 - 2030 (USD Billion)
- 5. Hypertension Drug Market – Asia Pacific
- 1. Asia Pacific: Hypertension Drug Market, by Condition, 2018 - 2030 (USD Billion)
- 2. Asia Pacific: Hypertension Drug Market, by Medication Type, 2018 - 2030 (USD Billion)
- 3. Asia Pacific: Hypertension Drug Market, by Distribution Channel, 2018 - 2030 (USD Billion)
- 4. Asia Pacific: Hypertension Drug Market, by Type, 2018 - 2030 (USD Billion)
- 5. Hypertension Drug Market – China
- 1. China: Hypertension Drug Market, by Condition, 2018 - 2030 (USD Billion)
- 2. China.: Hypertension Drug Market, by Medication Type, 2018 - 2030 (USD Billion)
- 3. China: Hypertension Drug Market, by Distribution Channel, 2018 - 2030 (USD Billion)
- 4. China: Hypertension Drug Market, by Type, 2018 - 2030 (USD Billion)
- 6. Hypertension Drug Market – India
- 1. India: Hypertension Drug Market, by Condition, 2018 - 2030 (USD Billion)
- 2. India.: Hypertension Drug Market, by Medication Type, 2018 - 2030 (USD Billion)
- 3. India: Hypertension Drug Market, by Distribution Channel, 2018 - 2030 (USD Billion)
- 4. India: Hypertension Drug Market, by Type, 2018 - 2030 (USD Billion)
- 7. Hypertension Drug Market – Japan
- 1. Japan: Hypertension Drug Market, by Condition, 2018 - 2030 (USD Billion)
- 2. Japan.: Hypertension Drug Market, by Medication Type, 2018 - 2030 (USD Billion)
- 3. Japan: Hypertension Drug Market, by Distribution Channel, 2018 - 2030 (USD Billion)
- 4. Japan: Hypertension Drug Market, by Type, 2018 - 2030 (USD Billion)
- 8. Hypertension Drug Market – Malaysia
- 1. Malaysia: Hypertension Drug Market, by Condition, 2018 - 2030 (USD Billion)
- 2. Malaysia.: Hypertension Drug Market, by Medication Type, 2018 - 2030 (USD Billion)
- 3. Malaysia: Hypertension Drug Market, by Distribution Channel, 2018 - 2030 (USD Billion)
- 4. Malaysia: Hypertension Drug Market, by Type, 2018 - 2030 (USD Billion)
- 9. Hypertension Drug Market – Indonesia
- 1. Indonesia: Hypertension Drug Market, by Condition, 2018 - 2030 (USD Billion)
- 2. Indonesia.: Hypertension Drug Market, by Medication Type, 2018 - 2030 (USD Billion)
- 3. Indonesia: Hypertension Drug Market, by Distribution Channel, 2018 - 2030 (USD Billion)
- 4. Indonesia: Hypertension Drug Market, by Type, 2018 - 2030 (USD Billion)
- 10. Hypertension Drug Market – South Korea
- 1. South Korea: Hypertension Drug Market, by Condition, 2018 - 2030 (USD Billion)
- 2. South Korea.: Hypertension Drug Market, by Medication Type, 2018 - 2030 (USD Billion)
- 3. South Korea: Hypertension Drug Market, by Distribution Channel, 2018 - 2030 (USD Billion)
- 4. South Korea: Hypertension Drug Market, by Type, 2018 - 2030 (USD Billion)
- 6. Hypertension Drug Market – Middle East & Africa
- 1. Middle East & Africa: Hypertension Drug Market, by Condition, 2018 - 2030 (USD Billion)
- 2. Middle East & Africa: Hypertension Drug Market, by Medication Type, 2018 - 2030 (USD Billion)
- 3. Middle East & Africa: Hypertension Drug Market, by Distribution Channel, 2018 - 2030 (USD Billion)
- 4. Middle East & Africa: Hypertension Drug Market, by Type, 2018 - 2030 (USD Billion)
- 5. Hypertension Drug Market – Saudi Arabia
- 1. Saudi Arabia: Hypertension Drug Market, by Condition, 2018 - 2030 (USD Billion)
- 2. Saudi Arabia: Hypertension Drug Market, by Medication Type, 2018 - 2030 (USD Billion)
- 3. Saudi Arabia: Hypertension Drug Market, by Distribution Channel, 2018 - 2030 (USD Billion)
- 4. Saudi Arabia: Hypertension Drug Market, by Type, 2018 - 2030 (USD Billion)
- 6. Hypertension Drug Market – South Africa
- 1. South Africa: Hypertension Drug Market, by Condition, 2018 - 2030 (USD Billion)
- 2. South Africa: Hypertension Drug Market, by Medication Type, 2018 - 2030 (USD Billion)
- 3. South Africa: Hypertension Drug Market, by Distribution Channel, 2018 - 2030 (USD Billion)
- 4. South Africa: Hypertension Drug Market, by Type, 2018 - 2030 (USD Billion)
- 7. Hypertension Drug Market – Israel
- 1. Israel: Hypertension Drug Market, by Condition, 2018 - 2030 (USD Billion)
- 2. Israel: Hypertension Drug Market, by Medication Type, 2018 - 2030 (USD Billion)
- 3. Israel: Hypertension Drug Market, by Distribution Channel, 2018 - 2030 (USD Billion)
- 4. Israel: Hypertension Drug Market, by Type, 2018 - 2030 (USD Billion)
- 8. Hypertension Drug Market – UAE
- 1. UAE: Hypertension Drug Market, by Condition, 2018 - 2030 (USD Billion)
- 2. UAE: Hypertension Drug Market, by Medication Type, 2018 - 2030 (USD Billion)
- 3. UAE: Hypertension Drug Market, by Distribution Channel, 2018 - 2030 (USD Billion)
- 4. UAE: Hypertension Drug Market, by Type, 2018 - 2030 (USD Billion)
- 7. Hypertension Drug Market – Latin America
- 1. Latin America: Hypertension Drug Market, by Condition, 2018 - 2030 (USD Billion)
- 2. Latin America: Hypertension Drug Market, by Medication Type, 2018 - 2030 (USD Billion)
- 3. Latin America: Hypertension Drug Market, by Distribution Channel, 2018 - 2030 (USD Billion)
- 4. Latin America: Hypertension Drug Market, by Type, 2018 - 2030 (USD Billion)
- 5. Hypertension Drug Market – Mexico
- 1. Mexico: Hypertension Drug Market, by Condition, 2018 - 2030 (USD Billion)
- 2. Mexico: Hypertension Drug Market, by Medication Type, 2018 - 2030 (USD Billion)
- 3. Mexico: Hypertension Drug Market, by Distribution Channel, 2018 - 2030 (USD Billion)
- 4. Mexico: Hypertension Drug Market, by Type, 2018 - 2030 (USD Billion)
- 6. Hypertension Drug Market – Brazil
- 1. Brazil: Hypertension Drug Market, by Condition, 2018 - 2030 (USD Billion)
- 2. Brazil: Hypertension Drug Market, by Medication Type, 2018 - 2030 (USD Billion)
- 3. Brazil: Hypertension Drug Market, by Distribution Channel, 2018 - 2030 (USD Billion)
- 4. Brazil: Hypertension Drug Market, by Type, 2018 - 2030 (USD Billion)
- 7. Hypertension Drug Market – Argentina
- 1. Argentina: Hypertension Drug Market, by Condition, 2018 - 2030 (USD Billion)
- 2. Argentina: Hypertension Drug Market, by Medication Type, 2018 - 2030 (USD Billion)
- 3. Argentina: Hypertension Drug Market, by Distribution Channel, 2018 - 2030 (USD Billion)
- 4. Argentina: Hypertension Drug Market, by Type, 2018 - 2030 (USD Billion)
- 10. Competitive Landscape
- 1. Expansion and Acquisition Analysis
- 1. Expansion
- 2. Acquisitions
- 2. Partnerships/Collaborations/Agreements/Exhibitions
- 11. Company Profiles
- 1. Takeda Pharmaceutical Co
- 1. Company Overview
- 2. Financial Performance
- 3. Product Benchmarking
- 4. Recent Development
- 2. Pfizer, Inc
- 1. Company Overview
- 2. Financial Performance
- 3. Product Benchmarking
- 4. Recent Development
- 3. Astra Zeneca Plc
- 1. Company Overview
- 2. Financial Performance
- 3. Product Benchmarking
- 4. Recent Development
- 4. Dr. Reddy's Laboratories
- 1. Company Overview
- 2. Financial Performance
- 3. Product Benchmarking
- 4. Recent Development
- 5. Novartis, Abbott
- 1. Company Overview
- 2. Financial Performance
- 3. Product Benchmarking
- 4. Recent Development
- 6. Sanofi
- 1. Company Overview
- 2. Financial Performance
- 3. Product Benchmarking
- 4. Recent Development
- 7. Bayer AG
- 1. Company Overview
- 2. Financial Performance
- 3. Product Benchmarking
- 4. Recent Development
- 8. Johnson and Johnson Services Inc
- 1. Company Overview
- 2. Financial Performance
- 3. Product Benchmarking
- 4. Recent Development
- 9. Gilead
- 1. Company Overview
- 2. Financial Performance
- 3. Product Benchmarking
- 4. Recent Development
- 10. GlaxoSmithKline Plc
- 1. Company Overview
- 2. Financial Performance
- 3. Product Benchmarking
- 4. Recent Development
- 11. Merck & Co. Inc
- 1. Company Overview
- 2. Financial Performance
- 3. Product Benchmarking
- 4. Recent Development
- 12. Actelion Ltd.
- 1. Company Overview
- 2. Financial Performance
- 3. Product Benchmarking
- 4. Recent Development
- 13. F. Hoffmann La-Roche Ltd
- 1. Company Overview
- 2. Financial Performance
- 3. Product Benchmarking
- 4. Recent Development
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.